Biolase Cash on Hand 2010-2023 | BIOL
Biolase cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Biolase Annual Cash on Hand
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$4 |
| 2021 |
$30 |
| 2020 |
$18 |
| 2019 |
$6 |
| 2018 |
$8 |
| 2017 |
$12 |
| 2016 |
$9 |
| 2015 |
$12 |
| 2014 |
$32 |
| 2013 |
$1 |
| 2012 |
$3 |
| 2011 |
$3 |
| 2010 |
$2 |
| 2009 |
$3 |
Biolase Quarterly Cash on Hand
(Millions of US $) |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$7 |
| 2023-03-31 |
$7 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$10 |
| 2022-06-30 |
$20 |
| 2022-03-31 |
$22 |
| 2021-12-31 |
$30 |
| 2021-09-30 |
$34 |
| 2021-06-30 |
$37 |
| 2021-03-31 |
$41 |
| 2020-12-31 |
$18 |
| 2020-09-30 |
$19 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$8 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$3 |
| 2018-03-31 |
$9 |
| 2017-12-31 |
$12 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$8 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$9 |
| 2016-09-30 |
$13 |
| 2016-06-30 |
$5 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$12 |
| 2015-09-30 |
$15 |
| 2015-06-30 |
$20 |
| 2015-03-31 |
$24 |
| 2014-12-31 |
$32 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$2 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$4 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$3 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$3 |
| 2011-12-31 |
$3 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$10 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$2 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$3 |
| 2010-03-31 |
$3 |
| 2009-12-31 |
$3 |
| 2009-09-30 |
$4 |
| 2009-06-30 |
$3 |
| 2009-03-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
